自2020年新型冠状病毒（severe acute respiratory syndrome coronavirus 2）全球大流行以来，病毒株几经变异，传染性增强，致病性减弱，人群疫苗接种率提高，国内疫情防控进入新的阶段。中国当代儿科杂志编辑委员会围产新生儿新型冠状病毒感染防控管理预案工作组于2020年1月和2020年3月，先后制定了第一版和第二版围产新生儿新型冠状病毒感染防控管理预案。为适应新的防控需求，有必要对管理预案进行更新，以更好地指导临床实践。因此，该工作组制定了第三版预案。
Abstract
Since the global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020, the virus has been evolving through mutations to acquire enhanced infectivity but reduced virulence. With a wide vaccination coverage among Chinese population, China is entering a new stage of SARS-CoV-2 infection control. The Working Group for the Prevention and Control of Neonatal SARS-CoV-2 Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics released the first and second editions of perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection in January and March 2020, respectively. In order to follow up new prevention and control needs, it is necessary to update the management plan to better guide clinical practice. Therefore, the Working Group formulated the 3rd-edition plan.
关键词
新型冠状病毒 /
围产医学 /
感染防控 /
新生儿
Key words
Severe acute respiratory syndrome coronavirus 2 /
Perinatology /
Prevention and control of infection /
Neonate
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention[J]. JAMA, 2020, 323(13): 1239-1242. PMID: 32091533. DOI: 10.1001/jama.2020.2648.
2 Wolf JM, Wolf LM, Bello GL, et al. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022[J]. J Med Virol, 2023, 95(1): e28366. PMID: 36458547. DOI: 10.1002/jmv.28366.
3 Cihan P. Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World[J]. Appl Soft Comput, 2021, 111: 107708. PMID: 34305491. PMCID: PMC8278839. DOI: 10.1016/j.asoc.2021.107708.
4 中国当代儿科杂志编辑委员会围产新生儿新型冠状病毒感染防控管理预案工作组. 围产新生儿新型冠状病毒感染防控管理预案(第一版)[J]. 中国当代儿科杂志, 2020, 22(2): 87-90. PMID: 32051071. PMCID: PMC7390004. DOI: 10.7499/j.issn.1008-8830.2020.02.001.
5 中国当代儿科杂志编辑委员会围产新生儿新型冠状病毒感染防控管理预案工作组. 围产新生儿新型冠状病毒感染防控管理预案(第二版)[J]. 中国当代儿科杂志, 2020, 22(3): 195-198. PMID: 32204752. PMCID: PMC7389602. DOI: 10.7499/j.issn.1008-8830.2020.03.003.
6 Piekos SN, Roper RT, Hwang YM, et al. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study[J]. Lancet Digit Health, 2022, 4(2): e95-e104. PMID: 35034863. PMCID: PMC8758153. DOI: 10.1016/S2589-7500(21)00250-8.
7 Shalish W, Lakshminrusimha S, Manzoni P, et al. COVID-19 and neonatal respiratory care: current evidence and practical approach[J]. Am J Perinatol, 2020, 37(8):780-791. PMID: 32359226. PMCID: PMC7356086. DOI: 10.1055/s-0040-1710522.
8 Sankaran D, Nakra N, Cheema R, et al. Perinatal SARS-CoV-2 infection and neonatal COVID-19: a 2021 update[J]. Neoreviews, 2021, 22(5): e284-e295. PMID: 33931474. DOI: 10.1542/neo.22-5-e1001.
9 Wu Y, Kang L, Guo Z, et al. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis[J]. JAMA Netw Open, 2022, 5(8): e2228008. PMID: 35994285. PMCID: PMC9396366. DOI: 10.1001/jamanetworkopen.2022.28008.
10 Akin IM, Kanburoglu MK, Tayman C, et al. Epidemiologic and clinical characteristics of neonates with late-onset COVID-19: 1-year data of Turkish Neonatal Society[J]. Eur J Pediatr, 2022, 181(5): 1933-1942. PMID: 35061093. PMCID: PMC8776552. DOI: 10.1007/s00431-021-04358-8.
11 Boly TJ, Reyes-Hernandez ME, Daniels EC, et al. Hyperglycemia and cytopenias as signs of SARS-CoV-2 delta variant infection in preterm infants[J]. Pediatrics, 2022, 149(6): e2021055331. PMID: 35237826. DOI: 10.1542/peds.2021-055331.
12 Godfred-Cato S, Bryant B, Leung J, et al. COVID-19-associated multisystem inflammatory syndrome in children—United States, March-July 2020[J]. MMWR Morb Mortal Wkly Rep, 2020, 69(32): 1074-1080. PMID: 32790663. PMCID: PMC7440126. DOI: 10.15585/mmwr.mm6932e2.
13 Raschetti R, Vivanti AJ, Vauloup-Fellous C, et al. Synthesis and systematic review of reported neonatal SARS-CoV-2 infections[J]. Nat Commun, 2020, 11(1): 5164. PMID: 33060565. PMCID: PMC7566441. DOI: 10.1038/s41467-020-18982-9.
14 Fierman AH. Foreword: neonatal intensive care unit preparedness for the novel Coronavirus Disease-2019 pandemic: a New York City hospital perspective[J]. Curr Probl Pediatr Adolesc Health Care, 2020, 50(4): 100801. PMID: 32513559. PMCID: PMC7245256. DOI: 10.1016/j.cppeds.2020.100801.
15 Unger S, Christie-Holmes N, Guvenc F, et al. Holder pasteurization of donated human milk is effective in inactivating SARS-CoV-2[J]. CMAJ, 2020, 192(31): E871-E874. PMID: 32646870. PMCID: PMC7828876. DOI: 10.1503/cmaj.201309.
16 Mitoulas LR, Sch?rer-Hernández NG, Liabat S. Breastfeeding, human milk and COVID-19—What does the evidence say?[J]. Front Pediatr, 2020, 8: 613339. PMID: 33330294. PMCID: PMC7714759. DOI: 10.3389/fped.2020.613339.
17 Ryan L, Pl?tz FB, van den Hoogen A, et al. Neonates and COVID-19: state of the art: Neonatal Sepsis series[J]. Pediatr Res, 2022, 91(2): 432-439. PMID: 34961785. PMCID: PMC8712275. DOI: 10.1038/s41390-021-01875-y.
PDF(501 KB)
